Hemogenyx Pharmaceuticals Plc (LON:HEMO)
177.25
-0.90 (-0.51%)
Jun 6, 2025, 4:50 PM BST
Hemogenyx Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
8.14M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Hemogenyx Pharmaceuticals News
- 4 days ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing - Accesswire
- 5 days ago - Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests - Accesswire
- 25 days ago - Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol - Accesswire
- 4 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing - Accesswire
- 5 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy - Accesswire
- 5 weeks ago - Hemogenyx Pharmaceuticals reports FY results - Seeking Alpha
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report - Accesswire
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces First Patient Safety - Accesswire